Effect of Milnacipran on Plasma Level of Vascular Endothelial Growth Factor in Major Depression

Psychopharmacol Bull. 2022 Oct 27;52(4):106-108.

Authors

Reiji Yoshimura¹, Atsuko Ikenouchi², Naomichi Okamoto³

Affiliations

¹ Yoshimura, Department of Psychiatry, University of Occupational and Environmental Health, Japan.
² Ikenouchi, Department of Psychiatry and Center of Dementia, Hospital of Center of Dementia, Hospital of University of Occupational and Environmental Health, Japan.
³ Okamoto, Department of Psychiatry, University of Occupational and Environmental Health, Japan.

PMID: 36339278
PMCID: PMC9611799

No abstract available

MeSH terms

Antidepressive Agents / pharmacology
Antidepressive Agents / therapeutic use
Cyclopropanes / therapeutic use
Depression
Depressive Disorder, Major* / drug therapy
Humans
Milnacipran / therapeutic use
Selective Serotonin Reuptake Inhibitors
Vascular Endothelial Growth Factor A / therapeutic use

Substances

Milnacipran
Vascular Endothelial Growth Factor A
Antidepressive Agents
Serotonin Uptake Inhibitors
Cyclopropanes